Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 20;15(24):6375-6382.
doi: 10.1021/acs.jpclett.4c01410. Epub 2024 Jun 10.

Effects of Macromolecular Cosolutes on the Kinetics of Huntingtin Aggregation Monitored by NMR Spectroscopy

Affiliations

Effects of Macromolecular Cosolutes on the Kinetics of Huntingtin Aggregation Monitored by NMR Spectroscopy

Francesco Torricella et al. J Phys Chem Lett. .

Abstract

The effects of two macromolecular cosolutes, specifically the polysaccharide dextran-20 and the protein lysozyme, on the aggregation kinetics of a pathogenic huntingtin exon-1 protein (hhtex1) with a 35 polyglutamine repeat, httex1Q35, are described. A unified kinetic model that establishes a direct connection between reversible tetramerization occurring on the microsecond time scale and irreversible fibril formation on a time scale of hours/days forms the basis for quantitative analysis of httex1Q35 aggregation, monitored by measuring cross-peak intensities in a series of 2D 1H-15N NMR correlation spectra acquired during the course of aggregation. The primary effects of the two cosolutes are associated with shifts in the prenucleation tetramerization equilibrium resulting in substantial changes in concentration of "preformed" httex1Q35 tetramers. Similar effects of the two cosolutes on the tetramerization equilibrium observed for a shorter, nonaggregating huntingtin variant with a 7-glutamine repeat, httex1Q7, lend confidence to the conclusions drawn from the fits to the httex1Q35 aggregation kinetics.

PubMed Disclaimer

Conflict of interest statement

Notes

The authors declare no competing financial interest.

Figures

Figure 1.
Figure 1.
Schematic representation of the unified model of httex1Q35 aggregation. The prenucleation tetramerization equilibrium (shown at the top) is coupled with monomer-independent conversion, chain elongation and fibril surface-mediated secondary nucleation stages (see text). The concentration of tetramers, [T], as a function of monomer concentration, [m], is expressed through the product of equilibrium constants, KT=Keq,12Keq,2.
Figure 2.
Figure 2.
Effects of cosolutes on the tetramerization equilibrium for httex1Q7. (A) Examples of concentration-dependent chemical shift changes (15N/1HN-δex) and effective transverse relaxation rates (15N-R2,eff; RF spin-lock field strength of 750 Hz) obtained for httex1Q7 in the absence of cosolutes (red) and in the presence of 200 mg/mL dextran-20 (blue) and 100 mg/mL hen egg white lysozyme (green). Experimental data are shown with open circles; continuous solid lines represent the global best-fit to the 3-state exchange model in panel (B). The data in the presence of lysozyme were not best-fit, and the dashed green lines are drawn solely to guide the eye. The reduced χ2 of the best-fit was 4.6. The full sets of concentration-dependent 15N/1HN-δex and 15N-R2,eff data obtained for httex1Q7 and best-fit to the model in panel (B), are provided in the SI, Figures S1 and S2, respectively. (B) The model of oligomerization used to fit the httex1Q7 data. The populations of each species (in monomer units; %) are reported for [httex1Q7] = 1.0 mM, in the absence of cosolutes (red) and in the presence of 200 mg/mL dextran-20 (blue). See SI, “Materials and Methods”, for NMR acquisition parameters and details of the fitting procedures. The NMR experiments were carried out at 5 °C and pH 6.5.
Figure 3.
Figure 3.
Aggregation profiles and temporal changes in the concentration of tetramers T (in monomer units) for httex1Q35 in the absence of cosolutes (A), in the presence of 200 mg/mL dextran-20 (B), and 100 mg/mL lysozyme (C). The experimental data, recorded at 5 °C (800 MHz) and normalized to the first time point (t = 0), are shown with open circles. The best-fit curves are shown as black continuous lines and were obtained from a global fit to the kinetic scheme in Figure 1 and the model described by eqs 1.1 and 1.2. Initial concentrations of each sample, mtot, are indicated on the plots. The following sets of initial conditions P(0) were used in the fits (in nanomolar, nM, units): {2; 4; 6} for httex1Q35 in the absence of cosolutes; {0.5; 1.0; 10} for httex1Q35 in the presence of dextran-20; and {0.5; 12; 60} in the presence of lysozyme. See SI, “Materials and Methods” for the details of the fitting procedure.
Figure 4.
Figure 4.
Time dependence of mature fibrils M, nuclei P, and the M/P ratios, simulated for httex1Q35 aggregation (5 °C) using the optimized parameters of the kinetic model in eqs 1.1 and 1.2 in the absence of cosolutes (A), and in the presence of 200 mg/mL dextran-20 (B) and 100 mg/mL lysozyme (C).

Similar articles

Cited by

References

    1. Zuccato C; Valenza M; Cattaneo E Molecular Mechanisms and Potential Therapeutical Targetsin in Huntington’s Disease. Physiol. Rev. 2010, 90, 905–981. - PubMed
    1. Kar K; Jayaraman M; Sahoo B; Kodali R; Wetzel R Critical Nucleus Size for Disease-Related Polyglutamine Aggregation Is Repeat-Length Dependent. Nat. Struct. Mol. Biol. 2011, 18, 328–336. - PMC - PubMed
    1. Wetzel R Exploding the Repeat Length Paradigm While Exploring Amyloid Toxicity in Huntington’s Disease. Acc. Chem. Res. 2020, 53, 2347–2357. - PubMed
    1. Bates GP; Dorsey R; Gusella JF; Hayden MR; Kay C; Leavitt BR; Nance M; Ross CA; Scahill RI; Wetzel R; et al. Huntington Disease. Nat. Rev. Dis. Primers 2015, 1, 15005. - PubMed
    1. Andresen JM; Gayan J; Djousse L; Roberts S; Brocklebank D; Cherny SS; Cardon LR; Gusella JF; MacDonald ME; Myers RH; et al. The Relationship between CAG Repeat Length and Age of Onset Differs for Huntington’s Disease Patients with Juvenile Onset or Adult Onset. Ann. Hum. Genet. 2007, 71, 295–301. - PubMed

MeSH terms

LinkOut - more resources